Acute myocardial infarction and acute kidney injury are life-threatening conditions caused by ischemia, resulting from reduced or blocked blood flow to organs. Although early restoration of blood flow improves survival, many ...
Sep 2, 2025
0
26
Compared with crushed ticagrelor, intravenous cangrelor provided immediate, effective platelet inhibition, with no increase in major bleeding and lower mortality rates in patients with acute myocardial infarction and cardiogenic ...
Sep 1, 2025
0
19
Among low-risk patients with acute MI who underwent early complete revascularization and received one month of dual antiplatelet therapy (DAPT), P2Y12 inhibitor monotherapy was noninferior to continued DAPT for adverse cardiovascular ...
Sep 1, 2025
0
18
Beta blockers—drugs commonly prescribed for a range of cardiac conditions, including heart attacks—provide no clinical benefit for patients who have had an uncomplicated myocardial infarction with preserved heart function. ...
Aug 30, 2025
0
132
For younger acute myocardial infarction (AMI) survivors, living in marginalized neighborhoods is associated with adverse outcomes, according to a study published online July 2 in JAMA Network Open.
Jul 10, 2025
0
9
Despite the global implementation of clinical algorithms designed to predict atherosclerotic cardiovascular disease based on traditional risk factors, the burden of this condition continues to rise. This is shown in a study ...
Jul 3, 2025
0
21
Left main coronary artery (LMCA) disease can lead to what's known as a "widowmaker" heart attack, so-called because of the low odds of survival. But this can be avoided if someone is given a stent to open up the narrowed ...
Jul 1, 2025
0
21
Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients with acute myocardial infarction (MI), according to a study published online June 13 in Nature ...
Jun 26, 2025
0
44
Heart attacks are the leading cause of death globally, yet some statistics from many different countries suggest these events declined in frequency since the COVID-19 pandemic.
May 30, 2025
0
44
In one of the largest studies of early cardiogenic shock (CS) patients, where blood flow is still functioning to vital organs, researchers demonstrated that 26% experienced worse outcomes, including care escalation, CS deterioration, ...
May 1, 2025
0
20
